EUVIMEDEUVIMED entdecken
Crossref

Engineering IL-10-Overexpressing MSCs via a Non-Viral PEG-PEI Nanoplatform for Potent Therapy of Inflammatory Bowel Disease

Wenting Zhang, Mingmei Yang, Jie Jing, Yingjie Tang, Liudi Wang, Hui Yang, Shuo Liu, Yong Liu, Yuanyuan Xie, Bin Wang iD

ACS Applied Bio Materials · 2026

DOI: 10.1021/acsabm.6c00543 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2026. Verfasst von Wenting Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Stem Cell Center, Nanjing Drum Tower Hospital, Clinical Medical College of Traditional Chinese and Western Medicine, Nanjing University of C…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Polyethylene Glycols, Polyethyleneimine, Inflammatory Bowel Diseases. Die Arbeit nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Project of Chinese Hospital Reform and Development Institute, Nanjing University, Clinical Research Special Fund of Nanjing Drum Tower Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic engineering of therapeutic cells is a key strategy to enhance cell-based therapies, yet current gene delivery methods—viral vectors, electroporation, and commercial non-viral reagents—are limited by safety concerns, high cost, operational complexity, cytotoxicity, and poor scalability. We developed a safe, efficient, low-cost, and scalable non-viral gene delivery platform using a polyethylene glycol-polyethyleneimine (PEG-PEI) copolymer to engineer mesenchymal stromal cells (MSCs) for inflammatory bowel disease (IBD) treatment. The PEG-PEI copolymer was synthesized via covalent conjugation and formed stable core−shell nanocomplexes (∼130 nm, +20 mV) that completely protected DNA at N/P ≥ 10. In primary human MSCs, this platform achieved 43.8% EGFP-positive MSCs and enhanced IL-10 and bFGF secretion by approximately 2-fold and 1.6-fold, respectively, compared to Lipofectamine 3000, without compromising cell viability or multipotency. Engineered IL-10-overexpressing MSCs (PEG-PEI-IL-10-MSCs) were constructed and evaluated in a dextran sulfate sodium-induced murine acute colitis model. PEG-PEI-IL-10-MSCs restored body weight, reduced disease activity, ameliorated colon shortening and histopathological damage with efficacy comparable to the first-line drug 5-ASA, and significantly outperformed conventionally engineered or unmodified MSCs. Mechanistically, the treatment promoted epithelial proliferation and goblet cell regeneration, drove macrophage polarization toward an M2-reparative phenotype, suppressed pro-inflammatory cytokines (TNF-α and IL-6), and selectively normalized pathological angiogenesis while preserving functional vasculature. This PEG-PEI platform effectively overcomes the critical bottleneck of difficult-to-transfect primary MSCs, providing a versatile tool for cell engineering and a foundation for next-generation synergistic cell-and-gene therapies for IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsPolyethylene GlycolsPolyethyleneimineInflammatory Bowel DiseasesInterleukin-10Biocompatible MaterialsHumansAnimalsMiceMaterials TestingParticle SizeGene Transfer TechniquesGene Therapy Agents

Stichwörter der Autor:innen

PEG-PEI copolymerengineered cellsinflammatory bowel diseasemesenchymal stromal cellsnon-viral gene delivery

Substanzen

Polyethylene GlycolsPolyethyleneimineInterleukin-10Biocompatible Materialspoly(ethylene glycol)-co-poly(ethyleneimine)

Autor:innen und Institutionen

  • Clinical Stem Cell Center, Nanjing Drum Tower Hospital, Clinical Medical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province210009, China.
  • Clinical Stem Cell Research Laboratory, Nanjing Drum Tower Hospital, College of Life Sciences, Nanjing Normal University, Nanjing, Jiangsu Province210008, China.
  • School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu Province211100, China.
  • Clinical Stem Cell Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu Province210009, China.
  • Clinical Stem Cell Center, Jiangsu Key Laboratory for Cardiovascular Information and Health Engineering Medicine, Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing210093, P. R. China.
  • Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Clinical Medical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province210008, China.

ORCID-Profile: Bin Wang

Förderung

  • National Natural Science Foundation of China
  • Project of Chinese Hospital Reform and Development Institute, Nanjing University
  • Clinical Research Special Fund of Nanjing Drum Tower Hospital
  • Nanjing Municipal Health Science and Technology Development Special Fund Project
  • Natural Science Foundation of Jiangsu Province of China

Zitieren

APA

Zhang, W., Yang, M., Jing, J., Tang, Y., Wang, L., Yang, H., Liu, S., Liu, Y., Xie, Y., & Wang, B. (2026). Engineering IL-10-Overexpressing MSCs via a Non-Viral PEG-PEI Nanoplatform for Potent Therapy of Inflammatory Bowel Disease. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c00543

Vancouver

Zhang W, Yang M, Jing J, Tang Y, Wang L, Yang H, et al. Engineering IL-10-Overexpressing MSCs via a Non-Viral PEG-PEI Nanoplatform for Potent Therapy of Inflammatory Bowel Disease. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c00543

BibTeX
@article{Zhang2026,
  author = {Zhang, Wenting and Yang, Mingmei and Jing, Jie and Tang, Yingjie and Wang, Liudi and Yang, Hui and Liu, Shuo and Liu, Yong and Xie, Yuanyuan and Wang, Bin},
  title = {Engineering IL-10-Overexpressing MSCs via a Non-Viral PEG-PEI Nanoplatform for Potent Therapy of Inflammatory Bowel Disease},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  doi = {10.1021/acsabm.6c00543}
}
Kostenlos starten →